UpdatesGeneral Updates
Medicamen Biotech received a cautionary letter from NSE for secretarial audit observations.
Medicamen Biotech LimitedMEDICAMEQ · Filed with the exchange
The company confirmed no impact on financials, operations, or other activities.
This serves as an advisory for future compliance.
No comments yet. Be the first.